

NCT02830360 Raw comparison:

Summary:
CHIA has 14 criteria while your personal folder has 17 criteria
Total found criteria: 14/14
Total not Found: 0/14
Total Extra: 3
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Prior Myocardial Infarction and                    │ Prior Myocardial Infarction and                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Sustained monomorphic VT documented on 12-lead ECG │ Sustained monomorphic VT documented on 12-lead ECG │
│ or rhythm strip terminated by pharmacologic means  │ or rhythm strip terminated by pharmacologic means  │
│ or DC cardioversion                                │ or DC cardioversion                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ =3 episodes of VT treated with antitachycardia     │ ≥3 episodes of VT treated with antitachycardia     │
│ pacing (ATP) at least one of which was symptomatic │ pacing (ATP) at least one of which was symptomatic │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ = 5 episodes of VT treated with antitachycardia    │ ≥ 5 episodes of VT treated with antitachycardia    │
│ pacing (ATP) regardless of symptoms                │ pacing (ATP) regardless of symptoms                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ =1 appropriate ICD shocks                          │ ≥1 appropriate ICD shocks                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ =3 VT episodes within 24 hours                     │ ≥3 VT episodes within 24 hours                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Unable or unwilling to provide informed consent    │ Unable or unwilling to provide informed consent    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Active ischemia (acute thrombus diagnosed by       │ Active ischemia (acute thrombus diagnosed by       │
│ coronary angiography or dynamic ST segment changes │ coronary angiography or dynamic ST segment changes │
│ demonstrated on ECG) or another reversible cause   │ demonstrated on ECG) or another reversible cause   │
│ of VT (e g drug-induced arrhythmia) had recent     │ of VT (e g drug-induced arrhythmia) had recent     │
│ acute coronary syndrome within 30 days coronary    │ acute coronary syndrome within 30 days coronary    │
│ revascularization (<90 days bypass surgery <30     │ revascularization (\<90 days bypass surgery \<30   │
│ days percutaneous coronary intervention) or have   │ days percutaneous coronary intervention) or have   │
│ CCS functional class IV angina Note that biomarker │ CCS functional class IV angina Note that biomarker │
│ level elevation alone after ventricular            │ level elevation alone after ventricular            │
│ arrhythmias does not denote acute coronary         │ arrhythmias does not denote acute coronary         │
│ syndrome or active ischemia                        │ syndrome or active ischemia                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Are ineligible to take the antiarrhythmic drug to  │ Are ineligible to take the antiarrhythmic drug to  │
│ which they would be assigned due to allergy        │ which they would be assigned due to allergy        │
│ intolerance or contraindication                    │ intolerance or contraindication                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Are known to have protruding left ventricular      │ Are known to have protruding left ventricular      │
│ thrombus or mechanical aortic and mitral valves    │ thrombus or mechanical aortic and mitral valves    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Have had a prior catheter ablation procedure for   │ Have had a prior catheter ablation procedure for   │
│ VT                                                 │ VT                                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Are in renal failure (Creatinine clearance <15     │ Are in renal failure (Creatinine clearance \<15    │
│ mL/min) have NYHA Functional class IV heart        │ mL/min) have NYHA Functional class IV heart        │
│ failure or a systemic illness likely to limit      │ failure or a systemic illness likely to limit      │
│ survival to <1 year                                │ survival to \<1 year                               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Have had recent ST elevation myocardial infarction │ Have had recent ST elevation myocardial infarction │
│ or non-ST elevation MI (< 30 days) note that       │ or non-ST elevation MI (\< 30 days) note that      │
│ biomarker elevation alone after ventricular        │ biomarker elevation alone after ventricular        │
│ arrhythmias does not denote MI                     │ arrhythmias does not denote MI                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Are pregnant                                       │ Are pregnant                                       │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒══════════════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                              │
╞══════════════════════════════════════════════════════════════════════════════════════════════════════╡
│ One of the following VT events while not being treated with amiodarone sotalol or another class I or │
│ class III antiarrhythmic drug) within the last 6 months                                              │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have minimum age of 18 Years                                                                    │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Presenting arrhythmia polymorphic VT or ventricular fibrillation (VF)                                │
╘══════════════════════════════════════════════════════════════════════════════════════════════════════╛